Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel disease

• 作 者: Xiao-Ying Si Didier Merlin Bo
• 机 构: InstituteforCleanEnergyandAdvancedMaterials,InstituteforBiomedicalSciences,AtlantaVeteransAffairsMed
• 出 处: 世界胃肠病学杂志：英文版
• 发表日期: 2016年34期
• 关键词: ORAL ADMINISTRATION Nanotherapeutic Cell SPECIFICITY INFLAMMATORY BOWEL disease
• 基金项目: Supported by the National Natural Science Foundation of China,No.51503172 and No.81571807,the Fundamental Research Funds for the Central Universities,No.SWU114086 and No.XDJK2015C067,the Scientific Re

Inflammatory bowel disease(IBD) is a chronic relapsing disease in gastrointestinal tract. Conventional medications lack the efficacy to offer complete remission in IBD therapy,and usually associate with serious side effects. Recent studies indicated that